BASIC SCIENCES, PHYSIOLOGY AND DIAGNOSTICS
| Project Title: |
|
Funding Agency: |
| Pain Prevalence in Hospitalized Adults |
|
St. Boniface Hospital Alumni Assc. |
| Professional Caregivers' Knowledge & Attitudes of Perinatal Palliative Care |
n/a |
|
| Determining the Relative Change Value of Plasma 1, 5-anhydrogluticol (1, 5-AG) for Monitoring Short-term Glycemic Control in Pregnant Women with diabetes |
Dr. Michael Helewa |
CLINICAL OBSTETRICS (Return to Top)
| Project Title: |
|
|
| Long term followup of mothers with acute fatty liver of pregnancy/HELLP and their offspring in Manitoba |
Dr. Carol Schneider |
|
| Perinatal Services & Outcomes in Manitoba - A Manitoba Health Deliverable |
|
MCHP |
| "High-dose" vs. "Low-variable-dose" misoprostol for mid-trimester induction of labour |
Dr. Mark Bernier (PI) |
|
| Exercise and Dietary Intervention during Pregnancy Results in Reduced Excessive Gestational Weight Gain | Dr. Margaret Morris (Co-I) |
University of Manitoba |
| Abortion and Mental Illness |
Dr. Margaret Burnett (PI) |
|
| Organon: Protocol 292002: Randomized, open-label, comparative multi-centre trial to evaluate contraceptive efficacy, cycle control, safety and acceptability of a monophasic combined oral contraceptive COC containing 2.5mg nomegestrol acetate (NOMAC) and 1.5mg estradiol (E2), compared to a monophasic COC containing 3mg drospirenone (DRSP) and 30ug ethinyl estradiol (EE) |
Dr. Helen Pymar (Co-I) |
|
| Maternal-Infant Research on Environmental Chemicals (MIREC) A national profile of inutero and lactational exposure to environmental contaminants |
Dr. Michael Helewa (PI) |
Health Canada |
| The Effects & Mechanisms of Antioxidants for Healthy Pregnancy (CT-MIROS) |
Dr. Michael Helewa (Cllbr) |
CIHR |
| Effects of Intentional delivery after preterm & prelabor rupture of membranes between 32 & 35 weeks of gestation: a multicentre-randomized & controlled trial |
Dr. Michael Helewa (Cllbr) |
CIHR |
| Multiple Courses of antenatal corticosteroids for preterm birth study (MACS) |
Dr. Michael Helewa (Co-I) |
CIHR |
| Access to Abortion in Canada |
Dr. Margaret Burnett (PI) |
|
| Assessment of patient demographics, access, and satisfaction with the abortion service in women who present to elective pregnancy termination at the Winnipeg Centre |
Dr. Helen Pymar (PI) |
|
| Phase III, multicentre, open-label (1-year extension study) to evaluate the safety of levonorgestrel and ethinylestradiol in a continuous daily regimen for oral contraception |
|
Solvay |
| Phase III, multicentre, open-label study to evaluate the safety and efficacy of levonorgestrel 90 mg and ethinylestradiol 20 mg in a continuous daily regimen for oral contraceptive 2005 | Dr. Richard Boroditsky (Cllbr) |
Solvay |
CLINICAL GYNECOLOGY (Return to Top)
| Project Title: |
Department Member(s): |
Funding Agency: |
| Audit Endoscopic Hysterectomies (SCH, TLH) |
|
|
| Outcomes & Complications of the Apogee Mesh System for treatment of vaginal vault prolapse |
Dr. Ken Maslow (Cllbr) |
|
| Randomized clinical trial comparing: TVT Secur System and TVTO for surgical management of stress urinary incontinence |
Dr. Ken Maslow (PI) |
|
| Patient characteristics contributing to success with vaginal pessaries in a nurse-run pessary clinic |
Ms. Barbara Lewthwaite, RN (PI) |
|
| Mature women's motivation for using and perception of the risks and benefits of natural health products (NHP) |
Dr. Richard Boroditsky |
|
| A retrospective Review of patients presenting with abnormal uterine bleeding in the Hysterectomy Alternatives Program: Evaluation of a new paradigm in diagnosing and managing abnormal uterine bleeding |
Dr. Richard Boroditsky (PI) |
|
| Evaluation of change in 10-year risk of coronary heart disease in menopausal women followed in the Mature Women's Centre |
Dr. Richard Boroditsky (PI) |
|
| Endometrial ablation performed in a procedure room compared to the operating room | Dr. Richard Boroditsky (Cllbr) |
|
| Effect of dose titration and dose tapering on the tolerability of desvanlafazine succinate in women with vasomotor symptoms associated with menopause |
Dr. Richard Boroditsky (Cllbr) |
|
| Efficacy & safety of 2 low-dose regimens of conjugated estrogen cream administered vaginally in post-menopausal women with atrophic vaginitis |
Dr. Richard Boroditsky (Cllbr) |
|
| Multicentre, double-blinded, placebo-controlled comparison of multiple doses of esterified estrogens and methyltestosterone, in combination and alone, in relieving vasomotor symptoms of postmenopausal women |
Dr. Richard Boroditsky (Co-I) |
|
| Uterine Artery Embolization for symptomatic fibroids |
Dr. Richard Boroditsky (PI) |
|
| Double-blinded, randomized, placebo-controlled study assessing the safety & efficacy of DVS SR for the treatment of vasomotor symptoms associated with menopause |
Dr. Richard Boroditsky (Co-I) |
Wyeth |
| CL 00635 Clinical Study to assess the safety & effectiveness of VizAblate Intrauterine Ultrasound-guided RF Ablation (IUUSgRFA) of submuccosal and intramural uterine fibroids on the reduction of pictorial blood loss assessment scores |
Dr. Richard Boroditsky (PI) |
Gyne-sonics |
EDUCATION (Return to Top)
| Project Title: | Funding Agency: | |
| Web-based education & enhanced student learning in the Obstetrics & Gynecology Clerkship Rotation | Dr. Margaret Burnett (PI) |
|
| Feasibility of using written station in the Multi Mini Interview (MMI) |
Dr. Margaret Burnett (PI) |